Ultrasep ES Pharm-Spezial RP8e is a silica-based HPLC column with an endcapped specialty C8 bonded phase, engineered for pharmaceutical applications that require balanced hydrophobicity and minimized silanol interactions. The endcapping process reduces residual silanol activity, resulting in sharper peak shapes and improved reproducibility, particularly for basic and polar analytes.
Compared to conventional C18 phases, the shorter C8 chains deliver faster elution and enhanced resolution for moderately hydrophobic compounds. The “Spezial” bonding chemistry ensures robustness, long lifetime, and reproducibility, making Pharm-Spezial RP8e ideal for pharmaceutical quality control and method development.
Ultrasep ES Pharm-Spezial RP8e combines specialty bonding with endcapping technology – the reliable choice for pharmaceutical laboratories seeking reproducible and efficient C8 separations.
Silica-based stationary phase with endcapped specialty C8 bonded chemistry
Reduced silanol activity for improved peak symmetry
Balanced hydrophobic retention with faster elution than C18
High reproducibility and robust column lifetime
Available particle size: 5 µm
Pharmaceutical impurity profiling and stability-indicating assays
Analysis of basic and polar drugs with improved peak shapes
Routine quality control in pharmaceutical production
Method development requiring robust and reproducible C8 selectivity
| Particle Size |
|
|---|---|
| Pore Size | 100 Å |
| Particle Type | |
| Separation Mode | |
| USP Code | |
| Endcapping | Yes |
| pH Range | 2 - 8 |
| Phase | Material Number |
|---|---|
| Ultrasep ES Pharm-Spezial RP8e, 5 µm | u15.ps8e. |